Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1997 1
2005 1
2011 1
2014 1
2015 2
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
[Validation and adhesion to GESIDA quality indicators in patients with HIV infection].
Riera M, Esteban H, Suarez I, Palacios R, Lozano F, Blanco JR, Valencia E, Ocampo A, Amador C, Frontera G, vonWichmann-de Miguel MA; GESIDA Study Group of the HIV quality indicators. Riera M, et al. Enferm Infecc Microbiol Clin. 2016 Jun-Jul;34(6):346-52. doi: 10.1016/j.eimc.2015.09.003. Epub 2015 Nov 1. Enferm Infecc Microbiol Clin. 2016. PMID: 26530224 Spanish.
The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients.
López-Diéguez M, Montes ML, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, Tural C, Hernando A, González-García J, Serrano L, Arribas JR; GESIDA 37/03-FIPSE 36465/03-NEAT IG5 Study Group. López-Diéguez M, et al. AIDS. 2011 Apr 24;25(7):899-904. doi: 10.1097/QAD.0b013e3283454174. AIDS. 2011. PMID: 21330908
Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.
Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA; GESIDA 7011 Study Group members. Pérez-Valero I, et al. J Antimicrob Chemother. 2018 Sep 1;73(9):2444-2451. doi: 10.1093/jac/dky212. J Antimicrob Chemother. 2018. PMID: 29897573 Free article. Clinical Trial.
[The problems of Candida infection in the HIV-positive patient].
Arrizabalaga Aguirreazaldegui J, Rodríguez Arrondo F, Iribarren Loyarte JA, von Wichmann de Miguel MA. Arrizabalaga Aguirreazaldegui J, et al. Among authors: von wichmann de miguel ma. Rev Clin Esp. 1997 Apr;197 Suppl 1:44-8. Rev Clin Esp. 1997. PMID: 9297206 Review. Spanish. No abstract available.
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S; GESIDA 7011 Study Group. Perez-Molina JA, et al. Lancet Infect Dis. 2015 Jul;15(7):775-84. doi: 10.1016/S1473-3099(15)00097-3. Epub 2015 Jun 7. Lancet Infect Dis. 2015. PMID: 26062881 Clinical Trial.
[A two-year history of arthritis of the hand].
Avellanal D, von Wichmann de Miguel MA, Rodríguez-Arrondo F, Iribarren JA. Avellanal D, et al. Among authors: von wichmann de miguel ma. Enferm Infecc Microbiol Clin. 2005 May;23(5):325-6. doi: 10.1157/13074974. Enferm Infecc Microbiol Clin. 2005. PMID: 15899184 Spanish. No abstract available.